ANTI GBM (GLOMERULAR BASEMENT MEMBRANE ) ANTIBODY - IFA

The Anti-GBM (Glomerular Basement Membrane) Antibody Test by IFA is a specialized blood test that detects antibodies directed against the glomerular basement membrane using the Indirect Immunofluorescence Assay (IFA) method. These autoantibodies are strongly associated with Anti-GBM disease (Goodpasture syndrome), a rare autoimmune disorder that primarily affects the kidneys and lungs.

In Anti-GBM disease, the immune system mistakenly attacks the basement membrane of the kidneys, leading to rapidly progressive kidney damage. It may also affect the lungs, causing pulmonary hemorrhage (bleeding into the lungs). Early detection through IFA testing enables prompt diagnosis and timely treatment, helping reduce the risk of permanent organ damage.

Benefits of the Test

• Detects Anti-GBM antibodies associated with autoimmune disease.
• Supports early diagnosis of Goodpasture syndrome.
• Helps evaluate autoimmune kidney disorders.
• Assists in diagnosing pulmonary-renal syndrome.
• Supports treatment planning and disease monitoring.
• Uses the highly sensitive Indirect Immunofluorescence Assay (IFA) technique.

Why Doctors Recommend This Test

Doctors may recommend the Anti-GBM Antibody Test by IFA for patients experiencing symptoms suggestive of autoimmune kidney or lung disease, including:

• Blood in the urine (hematuria)
• Protein in the urine
• Rapid decline in kidney function
• Swelling of the face, hands, or legs
• Coughing up blood (hemoptysis)
• Shortness of breath
• Fatigue and weakness
• Suspected rapidly progressive glomerulonephritis

The test is commonly ordered along with kidney function tests, urinalysis, ANCA antibodies, ANA profile, and other autoimmune investigations.

Preparation Before Test

• No fasting is required.
• Continue routine medications unless advised otherwise by your physician.
• Inform your healthcare provider about your medical history and ongoing medications.
• A blood sample is collected for laboratory analysis.

Normal Reporting Time

Reporting Time: Usually 3–7 working days, depending on laboratory processing protocols.

Who Should Take This Test?

This test is recommended for:

• Patients with suspected Goodpasture syndrome.
• Individuals with unexplained kidney inflammation.
• Patients with blood in urine or rapidly worsening kidney function.
• Individuals with unexplained lung bleeding.
• Patients being evaluated for autoimmune kidney disorders.
• Individuals referred by nephrologists, pulmonologists, or rheumatologists.

Patient-Friendly Summary

The Anti-GBM Antibody Test by IFA is a blood test that detects antibodies that mistakenly attack the glomerular basement membrane, an essential part of the kidneys' filtering system. These antibodies are associated with Goodpasture syndrome, a rare autoimmune disease that can affect both the kidneys and lungs. Symptoms may include blood in the urine, swelling, reduced kidney function, coughing up blood, and breathing difficulties. Early diagnosis is important because prompt treatment can help prevent permanent kidney damage and serious lung complications. The test is safe, requires only a blood sample, and generally does not require fasting.